Parathyroid hormone ameliorates osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity through p38 MAPK signaling

Diabetes mellitus (DM)-induced glucolipotoxicity is an element strongly contributing to alveolar bone deficiency. Parathyroid hormone (PTH) has been recognized as a predominant systemic mediator to stability physiological calcium in bone. This research aimed to uncover PTH’s potential position in ameliorating the osteogenic capability of human bone marrow mesenchymal stem cells (HBMSCs) in opposition to glucolipotoxicity. Optimum PTH concentrations and excessive glucose and palmitic acid (GP) had been administered to cells, adopted by alkaline phosphatase (ALP) staining and ALP exercise assay.

Quantitative real-time reverse transcription-polymerase chain response (qRT-PCR) and Immunoblot had been carried out for assessing mRNA and protein quantities, respectively. Cell counting equipment-8 (CCK-8) and circulate cytometry had been carried out for quantitating cell proliferation. Osteogenesis and oxidative stress had been decided, and the involvement of mitogen-activated protein kinase (MAPK) signaling was additional verified. About 1-50 mmol/ml GP considerably inhibited the osteogenic differentiation of HBMSCs. 10-9 mol/L PTH was discovered to be the optimum focus for HBMSC induction. PTH had no results on HBMSC proliferation, with or with out GP therapy.

PTH reversed insufficient osteogenesis and extreme oxidative stress in GP-treated HBMSCs. Mechanistically, PTH activated p38 MAPK signaling, whereas inhibiting p38 MAPK-suppressed PTH’s useful impacts on HBMSCs. Collectively, PTH promotes osteogenic differentiation in HBMSCs in opposition to glucolipotoxicity by way of p38 MAPK signaling.

 

MiR-139-5p Upregulation Alleviated Spontaneous Recurrent Epileptiform Discharge-induced Oxidative Stress and Apoptosis in Rat Hippocampal Neurons by way of Regulating the Notch Pathway

Epilepsy was characterised by the prevalence of spontaneous recurrent epileptiform discharges (SREDs) in neurons. Earlier research urged that microRNA (miR)-139-5p and the Notch pathway had been implicated in Epilepsy; nevertheless, their interplay remained imprecise. Rat main hippocampal neurons had been remoted and recognized by immunofluorescence staining.
The cells had been then used for SREDs mannequin development and additional subjected to circulate cytometry for apoptosis detection. Contents of lactate dehydrogenase (LDH), malondialdehyde (MDA), tremendous oxidase dismutase (SOD) contents, and reactive oxygen species (ROS) and the extent of mitochondrial membrane potential (MMP) had been decided utilizing industrial kits. Goal gene and potential binding websites of miR-139-5p had been predicted with TargetScan and confirmed by dual-luciferase reporter assay. Expressions of miR-139-5p, Notch pathway-related proteins and apoptosis-related proteins had been measured by quantitative real-time polymerase chain response (qRT-PCR) and Western blot as wanted. The outcomes confirmed that the hippocampal neurons had been microtubule-associated protein 2 (MAP2)-positive. MiR-139-5p was downregulated in SREDs mannequin cells.
SREDs promoted apoptosis and elevated the contents of LDH, MDA, and ROS and the extent of MMP whereas lowering miR-139-5p expression and SOD content material in cells, which was reversed by miR-139-5p overexpression. Notch-1 was acknowledged because the goal gene of miR-139-5p, and its expression was negatively regulated by miR-139-5p. Apart from, Notch-1 overexpression reversed the consequences of miR-139-5p upregulation on the expressions of Notch pathway-related proteins and apoptosis-related proteins, cell apoptosis, oxidative stress and MMP in SREDs-treated cells. Our outcomes indicated that miR-139-5p upregulation alleviated SREDs-induced oxidative stress and cell apoptosis by way of regulating the Notch pathway, which supplies new insights into the position of miRNA within the prevalence and improvement of epilepsy. This text is protected by copyright. All rights reserved.
Parathyroid hormone ameliorates osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity through p38 MAPK signaling
Parathyroid hormone ameliorates osteogenesis of human bone marrow mesenchymal stem cells against glucolipotoxicity through p38 MAPK signaling

A serological framework to analyze acute main and post-primary dengue circumstances reporting throughout the Philippines

Background: In dengue-endemic nations, concentrating on restricted management interventions to populations vulnerable to extreme illness may allow elevated effectivity. People who’ve had their first (main) dengue an infection are vulnerable to creating extra extreme secondary illness, thus might be focused for illness prevention. At the moment, there is no such thing as a dependable algorithm for figuring out main and post-primary (an infection with a couple of flavivirus) standing from a single serum pattern. On this research, we developed and validated an immune standing algorithm utilizing single acute serum samples from reporting sufferers and investigated dengue immuno-epidemiological patterns throughout the Philippines.
Strategies: Throughout 2015/2016, a cross-sectional pattern of 10,137 dengue case experiences supplied serum for molecular (anti-DENV PCR) and serological (anti-DENV IgM/G seize ELISA) assay. Utilizing combination modelling, we re-assessed IgM/G seroprevalence and estimated purposeful, illness day-specific, IgG:IgM ratios that categorised the reporting inhabitants as adverse, historic, main and post-primary for dengue. We validated our algorithm in opposition to WHO gold commonplace standards and investigated cross-reactivity with Zika by assaying a random subset for anti-ZIKV IgM and IgG. Lastly, utilizing our algorithm, we explored immuno-epidemiological patterns of dengue throughout the Philippines.
Outcomes: Our modelled IgM and IgG seroprevalence thresholds had been decrease than kit-provided thresholds. People anti-DENV PCR+ or IgM+ had been labeled as lively dengue infections (83.1%, 6998/8425). IgG- and IgG+ lively dengue infections on illness days 1 and a pair of had been categorised as main and post-primary, respectively, whereas these on illness days three to five with IgG:IgM ratios beneath and above 0.45 had been labeled as main and post-primary, respectively. A big proportion of post-primary dengue infections had elevated anti-ZIKV IgG inferring earlier Zika publicity. Our algorithm achieved 90.5% serological settlement with WHO commonplace apply. Submit-primary dengue infections had been extra prone to be older and current with extreme signs. Lastly, we recognized a spatio-temporal cluster of main dengue case reporting in northern Luzon throughout 2016.

AFMID Polyclonal Antibody

28578-100ul 100ul
EUR 252

AFMID Polyclonal Antibody

28578-50ul 50ul
EUR 187

Arylformamidase (AFMID) Antibody

20-abx175476
  • EUR 1205.00
  • EUR 578.00
  • 1 mg
  • 200 ug

Arylformamidase (AFMID) Antibody

20-abx171327
  • EUR 857.00
  • EUR 439.00
  • 1 mg
  • 200 ug

Arylformamidase (AFMID) Antibody

abx230202-100ug 100 ug
EUR 481

anti- AFMID antibody

FNab00202 100µg
EUR 505.25
Description: Antibody raised against AFMID

Anti-AFMID antibody

PAab00202 100 ug
EUR 355

AFMID siRNA

20-abx906957
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

AFMID siRNA

20-abx906958
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

AFMID Polyclonal Conjugated Antibody

C28578 100ul
EUR 397

AFMID cloning plasmid

CSB-CL714394HU-10ug 10ug
EUR 364
Description: A cloning plasmid for the AFMID gene.

AFMID Rabbit pAb

A14441-100ul 100 ul
EUR 308

AFMID Rabbit pAb

A14441-200ul 200 ul
EUR 459

AFMID Rabbit pAb

A14441-20ul 20 ul
EUR 183

AFMID Rabbit pAb

A14441-50ul 50 ul
EUR 223

AFMID Blocking Peptide

DF12814-BP 1mg
EUR 195

Human AFMID shRNA Plasmid

20-abx964802
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

Mouse AFMID shRNA Plasmid

20-abx977430
  • EUR 801.00
  • EUR 1121.00
  • 150 µg
  • 300 µg

Human Arylformamidase (AFMID) Protein

20-abx652587
  • EUR 578.00
  • EUR 258.00
  • EUR 1720.00
  • EUR 690.00
  • EUR 425.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

AFMID ELISA KIT|Human

EF007651 96 Tests
EUR 689

AFMID Recombinant Protein (Mouse)

RP114710 100 ug Ask for price

AFMID Recombinant Protein (Rat)

RP189482 100 ug Ask for price

AFMID Recombinant Protein (Human)

RP036508 100 ug Ask for price

Human Arylformamidase (AFMID) ELISA Kit

SEJ665Hu-10x96wellstestplate 10x96-wells test plate
EUR 4731.5
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Arylformamidase (AFMID) in Tissue homogenates, cell lysates and other biological fluids.

Human Arylformamidase (AFMID) ELISA Kit

SEJ665Hu-1x48wellstestplate 1x48-wells test plate
EUR 477.3
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Arylformamidase (AFMID) in Tissue homogenates, cell lysates and other biological fluids.

Human Arylformamidase (AFMID) ELISA Kit

SEJ665Hu-1x96wellstestplate 1x96-wells test plate
EUR 639
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Arylformamidase (AFMID) in Tissue homogenates, cell lysates and other biological fluids.

Human Arylformamidase (AFMID) ELISA Kit

SEJ665Hu-5x96wellstestplate 5x96-wells test plate
EUR 2575.5
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Arylformamidase (AFMID) in Tissue homogenates, cell lysates and other biological fluids.

Human Arylformamidase (AFMID) ELISA Kit

4-SEJ665Hu
  • EUR 4782.00
  • EUR 2526.00
  • EUR 640.00
  • 10 plates of 96 wells
  • 5 plates of 96 wells
  • 1 plate of 96 wells
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Arylformamidase (AFMID) in samples from Tissue homogenates, cell lysates and other biological fluids. with no significant corss-reactivity with analogues from other species.

Human Arylformamidase (AFMID) CLIA Kit

20-abx495758
  • EUR 7973.00
  • EUR 4246.00
  • EUR 981.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Arylformamidase (AFMID) ELISA Kit

20-abx150744
  • EUR 7378.00
  • EUR 3933.00
  • EUR 911.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

AFMID ELISA Kit (Human) (OKCD02010)

OKCD02010 96 Wells
EUR 831
Description: Description of target: Catalyzes the hydrolysis of N-formyl-L-kynurenine to L-kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.57 ng/mL

Human Arylformamidase(AFMID)ELISA Kit

QY-E03639 96T
EUR 361

Afmid ORF Vector (Mouse) (pORF)

ORF038238 1.0 ug DNA
EUR 506

AFMID ORF Vector (Human) (pORF)

ORF012170 1.0 ug DNA
EUR 354

Afmid ORF Vector (Rat) (pORF)

ORF063162 1.0 ug DNA
EUR 506

ELISA kit for Human AFMID (Arylformamidase)

ELK4511 1 plate of 96 wells
EUR 432
Description: A sandwich ELISA kit for detection of Arylformamidase from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Human Probable arylformamidase, AFMID ELISA KIT

ELI-49540h 96 Tests
EUR 824

Mouse Probable arylformamidase, Afmid ELISA KIT

ELI-49541m 96 Tests
EUR 865

AFMID sgRNA CRISPR Lentivector set (Human)

K0055601 3 x 1.0 ug
EUR 339

Afmid sgRNA CRISPR Lentivector set (Mouse)

K4725101 3 x 1.0 ug
EUR 339

Afmid sgRNA CRISPR Lentivector set (Rat)

K6061601 3 x 1.0 ug
EUR 339

ELISA kit for Human Probable arylformamidase (AFMID)

KTE60956-48T 48T
EUR 332
Description: Quantitative sandwich ELISA for measuring Human Probable arylformamidase (AFMID) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Probable arylformamidase (AFMID)

KTE60956-5platesof96wells 5 plates of 96 wells
EUR 2115
Description: Quantitative sandwich ELISA for measuring Human Probable arylformamidase (AFMID) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Probable arylformamidase (AFMID)

KTE60956-96T 96T
EUR 539
Description: Quantitative sandwich ELISA for measuring Human Probable arylformamidase (AFMID) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

AFMID sgRNA CRISPR Lentivector (Human) (Target 1)

K0055602 1.0 ug DNA
EUR 154

AFMID sgRNA CRISPR Lentivector (Human) (Target 2)

K0055603 1.0 ug DNA
EUR 154

AFMID sgRNA CRISPR Lentivector (Human) (Target 3)

K0055604 1.0 ug DNA
EUR 154

Afmid sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4725102 1.0 ug DNA
EUR 154

Afmid sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4725103 1.0 ug DNA
EUR 154

Afmid sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4725104 1.0 ug DNA
EUR 154

Afmid sgRNA CRISPR Lentivector (Rat) (Target 1)

K6061602 1.0 ug DNA
EUR 154

Afmid sgRNA CRISPR Lentivector (Rat) (Target 2)

K6061603 1.0 ug DNA
EUR 154

Afmid sgRNA CRISPR Lentivector (Rat) (Target 3)

K6061604 1.0 ug DNA
EUR 154

Afmid 3'UTR Luciferase Stable Cell Line

TU101497 1.0 ml Ask for price

AFMID Protein Vector (Mouse) (pPB-C-His)

PV152950 500 ng
EUR 603

AFMID Protein Vector (Mouse) (pPB-N-His)

PV152951 500 ng
EUR 603

AFMID Protein Vector (Mouse) (pPM-C-HA)

PV152952 500 ng
EUR 603

AFMID Protein Vector (Mouse) (pPM-C-His)

PV152953 500 ng
EUR 603

AFMID Protein Vector (Human) (pPB-C-His)

PV048677 500 ng
EUR 481

AFMID Protein Vector (Human) (pPB-N-His)

PV048678 500 ng
EUR 481

AFMID Protein Vector (Human) (pPM-C-HA)

PV048679 500 ng
EUR 481

AFMID Protein Vector (Human) (pPM-C-His)

PV048680 500 ng
EUR 481

AFMID Protein Vector (Human) (pPB-His-MBP)

PV320358 500 ng
EUR 481

AFMID Protein Vector (Human) (pPB-His-GST)

PV320359 500 ng
EUR 481

AFMID Protein Vector (Rat) (pPB-C-His)

PV252646 500 ng
EUR 603

AFMID Protein Vector (Rat) (pPB-N-His)

PV252647 500 ng
EUR 603

AFMID Protein Vector (Rat) (pPM-C-HA)

PV252648 500 ng
EUR 603

AFMID Protein Vector (Rat) (pPM-C-His)

PV252649 500 ng
EUR 603

Afmid 3'UTR GFP Stable Cell Line

TU250373 1.0 ml Ask for price

Afmid 3'UTR Luciferase Stable Cell Line

TU200373 1.0 ml Ask for price

AFMID 3'UTR GFP Stable Cell Line

TU050438 1.0 ml
EUR 1521

Afmid 3'UTR GFP Stable Cell Line

TU151497 1.0 ml Ask for price

AFMID 3'UTR Luciferase Stable Cell Line

TU000438 1.0 ml
EUR 1521

AFMID Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV706557 1.0 ug DNA
EUR 450

AFMID Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV706561 1.0 ug DNA
EUR 450

AFMID Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV706562 1.0 ug DNA
EUR 450

AFMID Protein Vector (Human) (pPM-N-D-C-HA)

PV320360 500 ng
EUR 552

AFMID Protein Vector (Human) (pPM-N-D-C-His)

PV320361 500 ng
EUR 552

AFMID sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0055605 3 x 1.0 ug
EUR 376

Afmid sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K4725105 3 x 1.0 ug
EUR 376

Afmid sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K6061605 3 x 1.0 ug
EUR 376

AFMID sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0055606 1.0 ug DNA
EUR 167

AFMID sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0055607 1.0 ug DNA
EUR 167

AFMID sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0055608 1.0 ug DNA
EUR 167

AFMID Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV706558 1.0 ug DNA
EUR 450

AFMID Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV706559 1.0 ug DNA
EUR 508

AFMID Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV706560 1.0 ug DNA
EUR 508

Afmid sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K4725106 1.0 ug DNA
EUR 167

Afmid sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K4725107 1.0 ug DNA
EUR 167

Afmid sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K4725108 1.0 ug DNA
EUR 167

Afmid sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K6061606 1.0 ug DNA
EUR 167

Afmid sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K6061607 1.0 ug DNA
EUR 167

Afmid sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K6061608 1.0 ug DNA
EUR 167

CD11b Antibody Antibody

ABD2911 100 ug
EUR 438

H2B Antibody Antibody

AF4659 200ul
EUR 376
Description: H2B Antibody Antibody detects endogenous levels of H2B.

anti- Antibody^Polyclonal antibody control antibody

LSMab09882 100 ug
EUR 438

Antibody

A1360-500 Ask for price

Anti-Anti-SEPT2 Antibody antibody

STJ25475 100 µl
EUR 277

Anti-Anti-SEPT5 Antibody antibody

STJ25477 100 µl
EUR 277
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.

Anti-Anti-SEPT8 Antibody antibody

STJ25479 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-SEPT2 Antibody antibody

STJ28365 100 µl
EUR 277

Anti-Anti-SEPT7 Antibody antibody

STJ28963 100 µl
EUR 277
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.

Anti-Anti-SEPT8 Antibody antibody

STJ117206 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-SEPT12 Antibody antibody

STJ117759 100 µl
EUR 277
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene.

Anti-Anti-MARCH6 Antibody antibody

STJ118549 100 µl
EUR 277

Anti-Anti-MARCH6 Antibody antibody

STJ118550 100 µl
EUR 277

Anti-Anti-MARCH7 Antibody antibody

STJ118752 100 µl
EUR 277

Anti-Anti-SEPT3 Antibody antibody

STJ118990 100 µl
EUR 277

Anti-Anti-SEPT1 antibody antibody

STJ119580 100 µl
EUR 277
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012]

Anti-Anti-SEPT7 Antibody antibody

STJ116214 100 µl
EUR 277
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19.

Anti-Anti-SEPT6 antibody antibody

STJ11100949 100 µl
EUR 277
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined.

Anti-Anti-SEPT9 Antibody antibody

STJ111369 100 µl
EUR 277
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.

Anti-Anti-SEPT11 Antibody antibody

STJ111530 100 µl
EUR 277

Anti-Anti-SEPT4 Antibody antibody

STJ112276 100 µl
EUR 277
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer.

Anti-Anti-MARCH9 Antibody antibody

STJ112609 100 µl
EUR 277

Anti-Anti-SEPT11 Antibody antibody

STJ113941 100 µl
EUR 277

Anti-Anti-SEPT11 Antibody antibody

STJ114081 100 µl
EUR 277

Anti-Anti-SEPT5 Antibody antibody

STJ114819 100 µl
EUR 277
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced.

Anti-Anti-MARCH8 Antibody antibody

STJ114828 100 µl
EUR 277

Ly1 Antibody Reactive (LYAR) Antibody

20-abx123734
  • EUR 411.00
  • EUR 592.00
  • 100 ul
  • 200 ul

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319900
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319901
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319905
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycoprotein Antibody (GP) Antibody

20-abx319913
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Ly1 Antibody Reactive (LYAR) Antibody

20-abx311665
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-Glycolipid Antibody (AGA) Antibody

20-abx004855
  • EUR 411.00
  • EUR 592.00
  • EUR 182.00
  • EUR 314.00
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Anti-Glycolipid Antibody (AGA) Antibody

abx036399-100ug 100 ug
EUR 391

Ly1 Antibody Reactive (LYAR) Antibody

20-abx008109
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul

Ly1 Antibody Reactive (LYAR) Antibody

20-abx014333
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Ly1 Antibody Reactive (LYAR) Antibody

abx033330-400ul 400 ul
EUR 523

Ly1 Antibody Reactive (LYAR) Antibody

abx033330-80l 80 µl
EUR 286

Ly1 Antibody Reactive (LYAR) Antibody

abx234901-100ug 100 ug
EUR 551

Anti-Glycolipid Antibody (AGA) Antibody

abx230204-100ug 100 ug
EUR 481

Ly1 Antibody Reactive (LYAR) Antibody

20-abx324434
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug

Monoclonal NGF/proNGF Neutralizing Antibody Antibody

AMM06679G 0.05mg
EUR 528
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E

Anti CD22 Antibody: CD22 Monoclonal Antibody

065-A-01mg 0,1 mg
EUR 267.5
Description: anti-CD22 monoclonal antibody

Anti CD22 Antibody: CD22 Monoclonal Antibody

065-A-1000ug 1000 ug
EUR 1282.5
Description: anti-CD22 monoclonal antibody

Anti-IgG1 Negative Control Antibody antibody

STJ16100881 1 mL
EUR 478

Anti-Noelin Antibody BIOTIN Antibody BIOTIN

STJ501938 100 µg
EUR 586

Anti-Noelin Antibody FITC Antibody FITC

STJ501939 100 µg
EUR 586

Anti-Noelin Antibody BIOTIN Antibody BIOTIN

STJ501940 100 µg
EUR 586

Anti-Noelin Antibody FITC Antibody FITC

STJ501941 100 µg
EUR 586

Antibody for Human alpha Tubulin Antibody

SPC-692D 0.1mg
EUR 354
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated.

Antibody for Human alpha Tubulin Antibody

SPC-692D-A390 0.1mg
EUR 401
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 390.

Antibody for Human alpha Tubulin Antibody

SPC-692D-A488 0.1mg
EUR 400
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 488.

Antibody for Human alpha Tubulin Antibody

SPC-692D-A565 0.1mg
EUR 400
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 565.

Antibody for Human alpha Tubulin Antibody

SPC-692D-A594 0.1mg
EUR 400
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 594.

Antibody for Human alpha Tubulin Antibody

SPC-692D-A633 0.1mg
EUR 400
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 633.

Antibody for Human alpha Tubulin Antibody

SPC-692D-A655 0.1mg
EUR 400
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 655.

Antibody for Human alpha Tubulin Antibody

SPC-692D-A680 0.1mg
EUR 400
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 680.

Antibody for Human alpha Tubulin Antibody

SPC-692D-A700 0.1mg
EUR 400
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 700.

Antibody for Human alpha Tubulin Antibody

SPC-692D-ALP 0.1mg
EUR 394
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Alkaline Phosphatase.

Antibody for Human alpha Tubulin Antibody

SPC-692D-APC 0.1mg
EUR 399
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC .
Conclusions: Our dengue immune standing algorithm can equip surveillance operations with the means to focus on dengue management efforts. The algorithm precisely recognized main dengue infections who’re vulnerable to future extreme illness.

Be First to Comment

Leave a Reply

Your email address will not be published.